Research goals in progressive supranuclear palsy

Movement Disorders

Volumn 15, Issue 3, 2000, Pages 446-458

  Litvan, Irene ^a   Dickson, Dennis W ^a   Buttner Ennever, Jean A ^a   Delacourte, Andre ^a   Hutton, Mike ^a   Dubois, Bruno ^a   Golbe, Lawrence I ^a   Hallett, Mark ^a   Schellenberg, Gerard D ^a   Standaert, David ^a   Brooks, David J ^a   Price, Donald ^a  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 8 METHYL 2,8 DIAZASPIRO[4.5]DECANE 1,3 DIONE; BROMOCRIPTINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NEUROTRANSMITTER; PERGOLIDE; PHYSOSTIGMINE; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASAL GANGLION; BEHAVIOR; CHOLINERGIC SYSTEM; CHROMOSOME 17; CLINICAL FEATURE; CLINICAL RESEARCH; COGNITION; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; EYE MOVEMENT; GABAERGIC SYSTEM; GLIA; HAPLOTYPE; HEREDITY; HUMAN; MOUSE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMAL; HUMAN; ORGANIZATIONAL OBJECTIVES; RESEARCH; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SUPRANUCLEAR PALSY, PROGRESSIVE; UNITED STATES;

EID: 0034074435     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200005)15:3<446::AID-MDS1005>3.0.CO;2-C     Document Type: Article

References (0)